HRTX
USDHeron Therapeutics Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$1.170
Kõrge
$1.190
Madal
$1.070
Maht
1.54M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
202.6M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
1.92M
Börs
NCM
Valuuta
USD
52 nädala vahemik
Seotud uudised
Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress
Generated Q3 2025 Net Revenue of $38.2 million and year-to-date revenue of $114.3 million; reaffirmed 2025 Net Revenue Guidance of $153 million - $163 million and adjusted EBITDA of $9.0 - $13.0 millionZYNRELEF® Net
Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors
CARY, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the appointment of Thomas Cusack to its Board
Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
CARY, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the Company will host a conference call
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.